An Artificial-Intelligence-Discovered Functional Ingredient, NRT_N0G5IJ, Derived from Pisum sativum, Decreases HbA1c in a Prediabetic Population

Discovery through Machine Learning and Preclinical Validation of Novel Anti-Diabetic Peptides

(2021) Rory Casey et al.   Biomedicines

The anti‐ageing effects of a natural peptide discovered by Artificial Intelligence

(2020) Kathy Kennedy et al.   INTERNATIONAL JOURNAL OF COSMETIC SCIENCE

The relationship between HbA1c reduction and healthcare costs among patients with type 2 diabetes: evidence from a U.S. claims database

(2020) Maureen J. Lage et al.   CURRENT MEDICAL RESEARCH AND OPINION

Preclinical Evaluation of a Food-Derived Functional Ingredient to Address Skeletal Muscle Atrophy

(2020) Roi Cal et al.   Nutrients

An Artificial Intelligence Characterised Functional Ingredient, Derived from Rice, Inhibits TNF-α and Significantly Improves Physical Strength in an Inflammaging Population

(2020) Kathy Kennedy et al.   Foods

In Vivo Rodent Models of Type 2 Diabetes and Their Usefulness for Evaluating Flavonoid Bioactivity

(2019) Jia-You Fang et al.   Nutrients

Bioactive peptides with antidiabetic properties: a review

(2019) Jiai Yan et al.   INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY

HbA1c monitoring interval in patients on treatment for stable type 2 diabetes. A ten-year retrospective, open cohort study

(2018) Sachiko Ohde et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Prediabetes and Cardiovascular Disease

(2018) Ben Brannick et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Macrovascular Complications in Patients with Diabetes and Prediabetes

(2017) Dou Huang et al.   Biomed Research International

Repurposing Drugs to Target the Diabetes Epidemic

(2016) Nigel Turner et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Peptide therapeutics: current status and future directions

(2015) Keld Fosgerau et al.   DRUG DISCOVERY TODAY

A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses

(2015) Katherine Esposito et al.   BMJ Open

Bioactive peptides and protein hydrolysates: research trends and challenges for application as nutraceuticals and functional food ingredients

(2015) Eunice CY Li-Chan   Current Opinion in Food Science

Thoughts on the progression of type 2 diabetes drug discovery

(2014) Harikrashna B. Bhatt   Expert Opinion on Drug Discovery

Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors

(2014) David Della-Morte et al.   PHARMACOGENOMICS

A Mediterranean diet improves HbA1c but not fasting blood glucose compared to alternative dietary strategies: a network meta-analysis

(2013) P. Carter et al.   JOURNAL OF HUMAN NUTRITION AND DIETETICS

Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future

(2013) Steven E Kahn et al.   LANCET

Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion

(2013) Harshita Chodavarapu et al.   PLoS One

Beta Cell Dysfunction and Insulin Resistance

(2013) Marlon E. Cerf   Frontiers in Endocrinology

The Future of Peptide-based Drugs

(2012) David J. Craik et al.   Chemical Biology & Drug Design

Standards of Medical Care in Diabetes--2013

(2012)   DIABETES CARE

Metformin - the gold standard in type 2 diabetes: what does the evidence tell us?

(2009) E. Bosi   DIABETES OBESITY & METABOLISM

Safety of protein hydrolysates, fractions thereof and bioactive peptides in human nutrition

(2009) G Schaafsma   EUROPEAN JOURNAL OF CLINICAL NUTRITION